CausalSentinel

Protein Dossier — PCSK7 (Proprotein convertase subtilisin/kexin type 7)

MR feasibility tier: A — Published pQTL-MR estimates exist for this protein (retrieved below - not computed here).

1. Published MR estimates (retrieved, not computed)

Outcome beta se p method nSNP cis/trans coloc
Triglycerides -0.0302 0.00544 2.77e-08 Wald ratio 1 cis NA
Total cholesterol -0.0235 0.00604 1.03e-04 Wald ratio 1 cis NA
Forced vital capacity (FVC) 0.00876 0.00239 2.56e-04 Wald ratio 1 cis NA
Diagnoses - main ICD10: M16 Coxarthrosis [arthrosis of hip] 0.0781 0.0225 5.14e-04 Wald ratio 1 cis NA
Diagnoses - main ICD10: I84 Haemorrhoids -0.065 0.02 0.00116 Wald ratio 1 cis NA
Heel bone mineral density (BMD) T-score automated -0.0122 0.00378 0.00122 Wald ratio 1 cis NA
Systemic lupus erythematosus 0.187 0.0584 0.00135 Wald ratio 1 cis NA
Non-cancer illness code self-reported: hypertension -0.0152 0.00505 0.0027 Wald ratio 1 cis NA
Non-cancer illness code self-reported: hayfever or allergic rhinitis -0.0339 0.0124 0.00631 Wald ratio 1 cis NA
Non-cancer illness code self-reported: high cholesterol -0.0216 0.00807 0.00732 Wald ratio 1 cis NA
Diagnoses - main ICD10: M17 Gonarthrosis [arthrosis of knee] -0.0584 0.0223 0.00884 Wald ratio 1 cis NA
Rheumatoid arthritis 0.0411 0.0161 0.0105 Wald ratio 1 cis NA
…and 124 more outcomes (see JSON)              

2. pQTL instrument availability (Tier-B probe)

Dataset Trait Author Year
prot-c-4459_68_2 PCSK7 Suhre K 2019

3. GWAS Catalog results — traits with signal at this locus

415 association rows across 208 traits (408 genome-wide significant rows). Associations are loci, not causal claims; the mapped gene at a locus is not necessarily the effector gene.

Trait best p lead SNP n assoc study MR status
Proprotein convertase subtilisin/kexin type 7 levels 5e-1552 rs35186251 5 GCST90248897 no MR -> candidate analysis
Soluble transferrin receptor concentration 2e-137 rs11216316 2 GCST90451684 no MR -> candidate analysis
Circulating TFRC levels 1e-103 rs508487 2 GCST90859941 no MR -> candidate analysis
Triglycerides 5e-91 rs508487 8 GCST007142 MR: beta=-0.0302, p=2.77e-08 (cis)
Monounsaturated fatty acids to total fatty acids percentage 4e-59 rs508487 26 GCST90502373 no MR -> candidate analysis
Apolipoprotein A1 levels 2e-57 rs74988348 4 GCST90019495 no MR -> candidate analysis
Cholesterol to total lipids ratio in medium HDL 4e-50 rs555766713 1 GCST90092893 no MR -> candidate analysis
Phospholipids to total lipids ratio in large VLDL 2e-49 rs555766713 1 GCST90092877 no MR -> candidate analysis
Ratio of triglycerides to phosphoglycerides 3e-49 rs555766713 1 GCST90092983 no MR -> candidate analysis
Cholesterol levels in chylomicrons and extremely large VLDL 3e-49 rs555766713 1 GCST90093040 no MR -> candidate analysis
Cholesteryl ester levels in large HDL 3e-48 rs555766713 1 GCST90092846 no MR -> candidate analysis
Free cholesterol levels in chylomicrons and extremely large 3e-48 rs555766713 1 GCST90093044 no MR -> candidate analysis
…and 196 more traits (see JSON)          

4. Phenome map — where this gene is a genetic locus, vs. where MR exists

Top diseases by Open Targets association (of 148 total). Associations are loci, not causal claims. The causal-status column is a four-state triage per pair: established (curated) = a curated clinical assertion exists (ClinGen/G2P/GEL/Orphanet/ClinVar — any validity level, MR adds little); exploratory rare-variant signal = ExWAS burden evidence without curation — a candidate NEW gene-disease relationship; common-variant locus = GWAS signal, classic pQTL-MR territory; multi-layer = burden+GWAS together, an allelic-series candidate (the strongest causal setup). Burden estimand is carrier-vs-noncarrier, not per-SD MR.

Disease genetic assoc. burden (ExWAS) causal status MR status
hypothyroidism 0.416 common-variant locus MR: beta=0.0223, p=0.0787 (cis)
familial lipoprotein lipase deficiency 0.385 common-variant locus no MR -> candidate analysis
placenta praevia 0.385 common-variant locus no MR -> candidate analysis
hyperlipidemia 0.384 common-variant locus no MR -> candidate analysis
Pericallosal lipoma 0.243 established (curated) no MR -> candidate analysis
Skin tags 0.243 established (curated) no MR -> candidate analysis
Hereditary breast and ovarian cancer syndrome 0.195 established (curated) no MR -> candidate analysis
Preauricular skin tag 0.195 established (curated) no MR -> candidate analysis
Midline facial cleft 0.195 established (curated) no MR -> candidate analysis
hereditary breast ovarian cancer syndrome 0.195 established (curated) no MR -> candidate analysis
myxedema 0.053 common-variant locus no MR -> candidate analysis
Hashimoto thyroiditis 0.05 common-variant locus no MR -> candidate analysis
asthma 0.048 common-variant locus MR: beta=-0.0141, p=0.0891 (cis)
diverticular disease 0.046 common-variant locus MR: beta=0.024, p=0.232 (cis)
autoimmune disease 0.045 common-variant locus no MR -> candidate analysis

Of the 15 rows above, 12 have no MR estimate in this resource. Across all retrieved diseases for this gene: 0 exploratory rare-variant signal(s), 0 multi-layer (allelic-series candidate) pair(s). Final triage still belongs to a statistical geneticist.

5. Downstream annotation (druggability & safety preview)

Layer Result
ChEMBL druggability 0 known modulators (Proprotein convertase subtilisin/kexin type 7)
gnomAD constraint pLI=2.3e-05, LOEUF=0.679 — LoF-tolerant
GWAS Catalog 157 unique SNPs / 384 rows
ClinVar 165 records; 1 pathogenic in sample of 30
PharmGKB/ClinPGx no annotations

Caveats declared by the tools

Sources

Provenance